Price Alert

Onconova Therapeutics Inc... (ONTX)

NASDAQ: ONTX · Real-Time Price · USD

1.00

0.00 (0.00%)

At close: Apr 02, 2024, 10:00 PM

Onconova Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.08B	15.94B	21,338B	5.41M	16.89B	16.39M	20.82M	25.24M	29.73M	34.22M	38.76M	42.61M	46.53M	50.77M	55.07M	59.38M	43.71M	48.01M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	244M	198M	1B	1K	1M	1K	1K	1K	1K	1K	1K	1K	10K	10K	10K	12K	140K	150K
Receivables	n/a	n/a	n/a	n/a	18M	18K	18K	18K	17K	17K	29K	28K	28K	27K	28K	29K	27K	38K
Inventory	n/a	n/a	n/a	n/a	n/a	1.48M	1.42M	1.45M	98K	734K	97K	807K	31K	277K	297K	n/a	n/a	394K
Other Current Assets	2.29B	2.92B	3,613B	3.51M	1.77B	263K	401K	303K	704K	68K	561K	303K	1.47M	306K	35K	529K	457K	213K
Total Current Assets	15.37B	18.86B	24,951B	8.92M	18.67B	18.15M	22.66M	27.01M	30.45M	35.04M	39.35M	43.75M	48.03M	51.38M	55.43M	59.94M	44.19M	48.65M
Property-Plant & Equipment	8M	9M	10B	12K	14M	18K	22K	26K	17K	21K	24K	28K	31K	35K	38K	42K	45K	49K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	252M	207M	11B	13K	15M	19K	23K	27K	18K	22K	25K	29K	41K	45K	48K	54K	185K	199K
Total Assets	15.62B	19.06B	24,962B	8.94M	18.69B	18.17M	22.68M	27.04M	30.47M	35.06M	39.37M	43.78M	48.07M	51.42M	55.48M	59.99M	44.38M	48.85M
Account Payables	4.76B	7.66B	8,186B	5.47M	6.17B	6.57M	5.62M	6.15M	5.07M	4.9M	3.86M	3.76M	3M	3.12M	2.76M	4.05M	4.29M	3.99M
Deferred Revenue	n/a	226M	226B	226K	227M	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K	226K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	7.35B	10.18B	11,307B	8.12M	3.51B	2.63M	3.38M	3.3M	3.37M	4.1M	3.96M	3.35M	3.23M	2.6M	3.13M	2.75M	2.98M	3.11M
Total Current Liabilities	7.35B	10.4B	11,533B	8.35M	9.91B	9.42M	9.22M	9.67M	8.67M	9.22M	8.05M	7.34M	6.46M	5.95M	6.12M	7.03M	7.5M	7.33M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	8M	2.66B	45,059B	2.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	530K	957K
Total Long-Term Liabilities	8M	2.66B	45,059B	2.62M	2.68B	2.73M	2.79M	2.85M	2.9M	2.96M	3.02M	3.07M	3.13M	3.19M	3.24M	3.3M	3.89M	4.37M
Total Liabilities	7.36B	13.06B	56,592B	10.97M	12.59B	12.16M	12.01M	12.52M	11.57M	12.19M	11.06M	10.41M	9.59M	9.13M	9.36M	10.32M	11.38M	11.7M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	71M	50M	36B	30K	253M	211K	210K	210K	210K	210K	209K	209K	209K	209K	209K	209K	158K	2.37M
Retained Earnings	-628.58B	-627.66B	-649,154B	-619.23M	-610.76B	-487.61M	-482.63M	-478.45M	-473.71M	-469.46M	-463.68M	-458.26M	-452.87M	-448.84M	-444.72M	-440.95M	-437.5M	-433.27M
Comprehensive Income	9M	-19M	-42B	-33K	-33M	-30K	-23K	-30K	-28K	-27K	-33K	-61K	-41K	-21K	-14K	-6K	2K	-2K
Shareholders Equity	8.26B	6B	-31,630B	-2.03M	-105.52B	6.01M	10.67M	14.52M	18.9M	22.88M	28.31M	33.37M	38.48M	42.29M	46.12M	49.67M	32.99M	37.15M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a